End points
dysphagia, chest pain, post‐procedure complaints
EROSIVE ESOPHAGITIS, EVENT, RECURRENCE, DYSPHAGIA
The primary end point was treatment success, defined as an improvement in AET to < 6 % on 24-hour pH impedance from baseline to 3 months in the intention-to-treat population. Secondary end points included improvement in the GERDQ score by > 50 %, requirement for PPI, and healing of erosive esophagitis. In the event of symptom recurrence, patients were asked to contact the study site. Treatment failure was defined as the need for resumption of PPI therapy (for at least three consecutive weeks) as assessed at clinic visits and/or if patients had post‐procedure complaints (dysphagia or chest pain) that required the EFTP procedure to be revised within 2 weeks after the procedure. Patients from the sham group classified as ‘treatment failure’ were offered EFTP after completing the 6-month follow-up and followed thereafter according to clinical practice.